Your session is about to expire
← Back to Search
Telehealth Follow-Up for Diabetes
N/A
Waitlist Available
Led By David C. Lee
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to month 12 post-diagnosis
Awards & highlights
Study Summary
This trial seeks to identify why newly-diagnosed diabetics don't follow up with care, and how to improve the process.
Who is the study for?
This trial is for emergency department patients in New York City or Long Island who speak English or Spanish, can consent to participate, and have an initial HbA1c test result of ≥ 6.5%, indicating new diabetes. It's not for those with a history of diabetes or conditions affecting the HbA1c test.Check my eligibility
What is being tested?
The study tests if telehealth bridge visits are effective in connecting patients newly diagnosed with diabetes in the ED to follow-up outpatient care, compared to standard practices. It includes chart reviews, interviews, and a randomized controlled trial component.See study design
What are the potential side effects?
Since this trial involves standard care procedures and telehealth services rather than medications or invasive treatments, there are no direct medical side effects associated with participating.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to month 12 post-diagnosis
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to month 12 post-diagnosis
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percent of Patients who Complete at least One In-Person Follow-up Outpatient Visit
Secondary outcome measures
Percent of Patients who Complete at least One Follow-Up Hemoglobin A1C (HbA1c) Test within 12 Months of Diagnosis
Percent of Patients who Complete at least One Follow-Up Hemoglobin A1C (HbA1c) Test within 6 Months of Diagnosis
Percent of Patients who Start on Diabetes Medications within 6 Months of Diagnosis
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Telehealth Bridge VisitsExperimental Treatment1 Intervention
Patients in the experimental arm will receive post-emergency department telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care.
Group II: ControlActive Control1 Intervention
Patients in the control arm will receive standard of care.
Find a Location
Who is running the clinical trial?
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,358 Previous Clinical Trials
4,315,041 Total Patients Enrolled
107 Trials studying Diabetes
138,663 Patients Enrolled for Diabetes
NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
839,526 Total Patients Enrolled
18 Trials studying Diabetes
20,252 Patients Enrolled for Diabetes
David C. LeePrincipal InvestigatorNYU Langone Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have never been diagnosed with diabetes.You do not have any medical condition that could affect the accuracy of the HbA1c test, like sickle cell disease or recent significant blood loss.You have a high HbA1c level from a recent lab test.
Research Study Groups:
This trial has the following groups:- Group 1: Telehealth Bridge Visits
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is it possible for me to become a participant in this medical study?
"This clinical trial is seeking approximately 200 individuals with diabetes aged between 20 and 70. Those hoping to be accepted into the study must meet this criteria."
Answered by AI
Are there any still available reservations for participants in this trial?
"The trial initiation date and last update on clinicaltrials.gov confirm that this medical research project is not currently accepting participants. Nevertheless, there are 1409 other studies actively searching for candidates at the moment."
Answered by AI
Is the age range for this research study limited to those 85 years or younger?
"It is specified that participants of this clinical trial must be between the ages of 20 and 70. Alternatively, there are 193 studies available for minors aged 18 or younger and 1088 trials specifically designed to serve geriatric populations above 65 years old."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger